Article
Intermediate molecular phenotypes to identify genetic markers of anthracycline-induced cardiotoxicity risk
2023-01-06
Abstract excerpt
Cardiotoxicity due to anthracyclines (CDA) affects cancer patients, but we cannot predict who may suffer from this complication. CDA is a complex disease whose polygenic component is mainly unidentified. We propose that levels of intermediate molecular phenotypes in the myocardium associated with histopathological damage could explain CDA susceptibility; so that variants of genes encoding these intermediate molecu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cbfef36d-cd59-5042-999f-25211ed40caa
- DOI
- 10.1101/2023.01.05.522844
